Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 76851-76900 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06847750
Elastography Ultrasound in Localized Scleroderma (Morphea) Study
N/AEnrolling by invitation
20 participants
Started: Mar 10, 2023 · Completed: Dec 31, 2026
1 condition4 sponsors1 location
NCT05710510
Rural Engagement in TelemedTeam for Options in Obesity Treatment Solutions
NAActive, not recruiting
560 participants
Started: Mar 10, 2023 · Completed: Sep 30, 2026
2 conditions2 sponsors1 location
NCT06402149
Comparison of 2 Different Methods in Infraclavicular Block
N/AEnrolling by invitation
60 participants
Started: Mar 10, 2023 · Completed: Aug 16, 2024
3 conditions1 sponsor1 location
NCT05800028
Memory and Social Interactions
N/ARecruiting
192 participants
Started: Mar 10, 2023 · Completed: Dec 31, 2026
2 conditions3 sponsors1 location
NCT05519254
Lactoferrin and Lysozyme Supplementation for Long-term Diarrhea Sequelae
PHASE3Recruiting
600 participants
Started: Mar 10, 2023 · Completed: Dec 31, 2026
3 conditions2 sponsors4 locations
NCT05826860
Storytelling and Mindfulness for Graduate Student Wellbeing
NARecruiting
20 participants
Started: Mar 10, 2023 · Completed: May 31, 2027
3 conditions1 sponsor1 location
NCT05640609
Capeox Regimen Combined With Sintilimab and Bevacizumab for Gastric Cancer
PHASE1/PHASE2Recruiting
57 participants
Started: Mar 10, 2023 · Completed: Nov 1, 2026
1 condition1 sponsor1 location
NCT06228859
Evaluation of Locator Versus TITACH Attachment for Mandibular Overdentures.
NARecruiting
36 participants
Started: Mar 10, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05438264
Effect of Donepezil on Speech Recognition in Cochlear Implant Users
EARLY_PHASE1Active, not recruiting
50 participants
Started: Mar 10, 2023 · Completed: Sep 1, 2026
1 condition1 sponsor1 location
NCT05683184
OMAR Opioid Use Disorder
PHASE1Recruiting
30 participants
Started: Mar 10, 2023 · Completed: Dec 15, 2025
2 conditions2 sponsors1 location
NCT06339814
Eye Movement Desensitization and Reprocessing Group Treatment for Caregivers of Pediatric Brain Tumor Patients
NARecruiting
48 participants
Started: Mar 10, 2023 · Completed: Nov 30, 2024
1 condition1 sponsor1 location
NCT05758987
Blended Treatment för PTSD: A New Format of Computer-Assisted Trauma-Focused Cognitive Behavioral Therapy
NARecruiting
160 participants
Started: Mar 10, 2023 · Completed: Mar 10, 2026
2 conditions4 sponsors1 location
NCT05778825
A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors
PHASE2Recruiting
60 participants
Started: Mar 10, 2023 · Completed: Mar 31, 2026
2 conditions1 sponsor1 location
NCT05779917
Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers
PHASE1Recruiting
30 participants
Started: Mar 10, 2023 · Completed: Mar 10, 2036
4 conditions2 sponsors1 location
NCT05350761
Rare Tumors and Cancer Predisposition in Individuals and Families
N/ARecruiting
500 participants
Started: Mar 10, 2023 · Completed: Dec 31, 2035
4 conditions1 sponsor2 locations
NCT05818774
End-on Versus Parallel Radiofrequency Lesioning for Neurotomy of the Cervical Medial Branch Nerves
NARecruiting
72 participants
Started: Mar 10, 2023 · Completed: Mar 31, 2027
2 conditions1 sponsor3 locations
NCT04450966
Adolescent Substance Use Prevention Intervention Research Study in Pediatric Primary Care
NAActive, not recruiting
406 participants
Started: Mar 10, 2023 · Completed: Mar 31, 2026
3 conditions4 sponsors3 locations
NCT05800704
Support of Colonization Resistance of the Gut Microbiota with the Synbiotic Food Supplement Nagasin®
NAActive, not recruiting
49 participants
Started: Mar 10, 2023 · Completed: Mar 31, 2025
1 condition6 sponsors6 locations
NCT05781139
Comparative Study Between Alzheimer's and Multi-infarct Dementia
N/ARecruiting
76 participants
Started: Mar 10, 2023 · Completed: Feb 21, 2026
1 condition1 sponsor1 location
NCT05790330
Mind and Skin - the Neurocutaneous Axis in Atopic Eczema
N/ARecruiting
90 participants
Started: Mar 10, 2023 · Completed: Jun 1, 2027
1 condition2 sponsors1 location
NCT06114433
Three-dimensional Upper Gastrointestinal Tract Model
NARecruiting
60 participants
Started: Mar 10, 2023 · Completed: Feb 29, 2024
1 condition1 sponsor1 location
NCT05819008
Remote Neuropsychological Assessment of Patients With Neurological Disorders and Injuries
N/ARecruiting
350 participants
Started: Mar 10, 2023 · Completed: Dec 31, 2025
6 conditions2 sponsors1 location
NCT05289713
Appendectomy vs. Symptomatic Treatment in Uncomplicated Acute Appendicitis Among Pediatric Patients
NARecruiting
64 participants
Started: Mar 10, 2023 · Completed: Dec 31, 2025
1 condition5 sponsors1 location
NCT05784688
Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
140 participants
Started: Mar 10, 2023 · Completed: Dec 31, 2028
4 conditions2 sponsors11 locations
NCT05644496
ZYNRELEF for Pain Management in Total Knee Arthroplasty
PHASE4Recruiting
242 participants
Started: Mar 9, 2023 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT05701865
Biphasic Effects of Acute Alcohol Intoxication on Bystander Intervention
NARecruiting
192 participants
Started: Mar 9, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05626777
Symptoms Control and adhErenCe Assessment During Treatment With MepolizUmab New pREfilled Devices
PHASE4Active, not recruiting
20 participants
Started: Mar 9, 2023 · Completed: Jul 31, 2026
1 condition2 sponsors8 locations
NCT05716919
Multiple Ascending Dose Study of CG200745 'Ivaltinostat' Oral Capsule
PHASE1Active, not recruiting
32 participants
Started: Mar 9, 2023 · Completed: Dec 31, 2023
3 conditions1 sponsor1 location
NCT06189820
Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases
PHASE2Recruiting
70 participants
Started: Mar 9, 2023 · Completed: Mar 9, 2027
4 conditions1 sponsor1 location
NCT05329792
L19IL2/L19TNF in Skin Cancer Patients
PHASE2Recruiting
70 participants
Started: Mar 9, 2023 · Completed: Dec 31, 2024
7 conditions1 sponsor14 locations
NCT05689151
A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.
N/ARecruiting
183 participants
Started: Mar 9, 2023 · Completed: May 31, 2027
2 conditions1 sponsor30 locations
NCT05728658
The Study of ICP-248 in Patients With Mature B-cell Malignancies
PHASE1Recruiting
191 participants
Started: Mar 9, 2023 · Completed: Oct 30, 2026
1 condition1 sponsor22 locations
NCT05759676
Efficacy and Safety of Polymer-free Amphilimus-eluting Stent According to the Diabetes
N/ARecruiting
1,800 participants
Started: Mar 9, 2023 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT06072768
Dynamic Treatment Regiments for Glucocorticoid Tapering
PHASE2Recruiting
200 participants
Started: Mar 9, 2023 · Completed: Mar 1, 2030
1 condition2 sponsors2 locations
NCT06334809
INSIDE: Identification of Genomic Screening Pathways in Cancer Patients With DNA Repair Alterations
N/ARecruiting
400 participants
Started: Mar 9, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor2 locations
NCT05136820
Flow Regulation by Opening the SepTum in Patients With Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study
NAActive, not recruiting
15 participants
Started: Mar 9, 2023 · Completed: Feb 28, 2029
2 conditions1 sponsor2 locations
NCT05739383
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
PHASE3Active, not recruiting
14,012 participants
Started: Mar 9, 2023 · Completed: Apr 16, 2029
1 condition1 sponsor990 locations
NCT05735483
A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
PHASE3Enrolling by invitation
310 participants
Started: Mar 9, 2023 · Completed: Apr 30, 2029
2 conditions1 sponsor94 locations
NCT05845489
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION)
PHASE4Recruiting
9,930 participants
Started: Mar 9, 2023 · Completed: Mar 31, 2030
1 condition7 sponsors1 location
NCT05798949
Chronic Pain Rehabilitation in Patients With Small Fiber Neuropathy
NARecruiting
10 participants
Started: Mar 9, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor2 locations
NCT05557877
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
PHASE2Recruiting
100 participants
Started: Mar 9, 2023 · Completed: Jan 30, 2027
1 condition2 sponsors4 locations
NCT06114147
Cardiac Flow Measurements in Pregnant Women by Non Invasive Techniques
NARecruiting
150 participants
Started: Mar 9, 2023 · Completed: Jun 30, 2024
2 conditions1 sponsor1 location
NCT05210374
Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
PHASE1Recruiting
24 participants
Started: Mar 9, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05786859
The Efficacy and Safety of Rifaximin Treatment
EARLY_PHASE1Recruiting
124 participants
Started: Mar 9, 2023 · Completed: Oct 31, 2025
6 conditions1 sponsor1 location
NCT06404437
Detection of Aortic Stenosis With Smartphone Auscultation Using Machine Learning (HEARTBEAT-Pilot)
N/ARecruiting
100 participants
Started: Mar 9, 2023 · Completed: Oct 1, 2024
1 condition2 sponsors1 location
NCT05380401
Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants
NARecruiting
328 participants
Started: Mar 9, 2023 · Completed: Apr 30, 2028
1 condition2 sponsors7 locations
NCT05655182
A Study of BLB-201 RSV Vaccine in Infants and Children
PHASE1/PHASE2Recruiting
137 participants
Started: Mar 9, 2023 · Completed: Dec 23, 2026
1 condition1 sponsor11 locations
NCT05965284
Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM)
PHASE4Recruiting
40 participants
Started: Mar 9, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06717139
Recurrence and Predictive OCT Biomarkers in Quiescent Neovascular AMD
N/AActive, not recruiting
220 participants
Started: Mar 9, 2023 · Completed: May 9, 2027
3 conditions1 sponsor1 location
NCT05340738
AI-Based Fidelity Feedback to Enhance CBT
NARecruiting
425 participants
Started: Mar 9, 2023 · Completed: Jan 31, 2026
2 conditions3 sponsors1 location